Literature DB >> 12819065

Variable lipoprotein genes of Mycoplasma agalactiae are activated in vivo by promoter addition via site-specific DNA inversions.

Ravenna Flitman-Tene1, Sigalit Mudahi-Orenstein, Sharon Levisohn, David Yogev.   

Abstract

Mycoplasma agalactiae, the etiological agent of contagious agalactia of small ruminants, has a family of related genes (avg genes) which encode surface lipoprotein antigens that undergo phase variation. A series of 13 M. agalactiae clonal isolates, obtained from one chronically infected animal over a period of 7 months, were found to undergo major rearrangement events within the avg genomic locus. We show that these rearrangements regulate the phase-variable expression of individual avg genes. Northern blot analysis and reverse transcription-PCR showed that only one avg gene is transcribed, while the other avg genes are transcriptionally silent. Sequence analysis and primer extension experiments with two M. agalactiae clonal isolates showed that a specific 182-bp avg 5' upstream region (avg-B(2)) that is present as a single chromosomal copy serves as an active promoter and exhibits a high level of homology with the vsp promoter of the bovine pathogen Mycoplasma bovis. PCR analysis showed that each avg gene is associated with the avg-B(2) promoter in a subpopulation of cells that is present in each subclone. Multiple sequence-specific sites for DNA recombination (vis-like), which are presumably recognized by site-specific recombinase, were identified within the conserved avg 5' upstream regions of all avg genes and were found to be identical to the recombination sites of the M. bovis vsp locus. In addition, a gene encoding a member of the integrase family of tyrosine site-specific recombinases was identified adjacent to the variable avg locus. The molecular genetic basis for avg phase-variable expression appears to be mediated by site-specific DNA inversions occurring in vivo that allow activation of a silent avg gene by promoter addition. A model for the control of avg genes is proposed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12819065      PMCID: PMC162021          DOI: 10.1128/IAI.71.7.3821-3830.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  The vsp locus of Mycoplasma bovis: gene organization and structural features.

Authors:  I Lysnyansky; K Sachse; R Rosenbusch; S Levisohn; D Yogev
Journal:  J Bacteriol       Date:  1999-09       Impact factor: 3.490

Review 2.  Molecular switches--the ON and OFF of bacterial phase variation.

Authors:  I R Henderson; P Owen; J P Nataro
Journal:  Mol Microbiol       Date:  1999-09       Impact factor: 3.501

3.  Mechanism of antigenic variation in Mycoplasma pulmonis: interwoven, site-specific DNA inversions.

Authors:  B Bhugra; L L Voelker; N Zou; H Yu; K Dybvig
Journal:  Mol Microbiol       Date:  1995-11       Impact factor: 3.501

4.  Expression of the pMGA genes of Mycoplasma gallisepticum is controlled by variation in the GAA trinucleotide repeat lengths within the 5' noncoding regions.

Authors:  M D Glew; N Baseggio; P F Markham; G F Browning; I D Walker
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

Review 5.  Transposition and site-specific recombination: adapting DNA cut-and-paste mechanisms to a variety of genetic rearrangements.

Authors:  B Hallet; D J Sherratt
Journal:  FEMS Microbiol Rev       Date:  1997-09       Impact factor: 16.408

Review 6.  Contagious agalactia of small ruminants: current knowledge concerning epidemiology, diagnosis and control.

Authors:  D Bergonier; X Berthelot; F Poumarat
Journal:  Rev Sci Tech       Date:  1997-12       Impact factor: 1.181

Review 7.  Mycoplasma bovis as an agent of mastitis, pneumonia, arthritis and genital disorders in cattle.

Authors:  H Pfützner; K Sachse
Journal:  Rev Sci Tech       Date:  1996-12       Impact factor: 1.181

8.  Genetic variation among Mycoplasma agalactiae isolates detected by the variant surface lipoprotein gene (vspA) of Mycoplasma bovis.

Authors:  R Flitman-Tene; S Levisohn; R Rosenbusch; E Rapoport; D Yogev
Journal:  FEMS Microbiol Lett       Date:  1997-11-01       Impact factor: 2.742

9.  Leucine alters the interaction of the leucine-responsive regulatory protein (Lrp) with the fim switch to stimulate site-specific recombination in Escherichia coli.

Authors:  P L Roesch; I C Blomfield
Journal:  Mol Microbiol       Date:  1998-02       Impact factor: 3.501

Review 10.  Molecular biology and pathogenicity of mycoplasmas.

Authors:  S Razin; D Yogev; Y Naot
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

View more
  9 in total

1.  Xer1-mediated site-specific DNA inversions and excisions in Mycoplasma agalactiae.

Authors:  Stefan Czurda; Wolfgang Jechlinger; Renate Rosengarten; Rohini Chopra-Dewasthaly
Journal:  J Bacteriol       Date:  2010-06-18       Impact factor: 3.490

2.  Occurrence, plasticity, and evolution of the vpma gene family, a genetic system devoted to high-frequency surface variation in Mycoplasma agalactiae.

Authors:  Laurent-Xavier Nouvel; Marc Marenda; Pascal Sirand-Pugnet; Eveline Sagné; Michelle Glew; Sophie Mangenot; Valérie Barbe; Aurélien Barré; Stéphane Claverol; Christine Citti
Journal:  J Bacteriol       Date:  2009-04-17       Impact factor: 3.490

3.  The Vsa shield of Mycoplasma pulmonis is antiphagocytic.

Authors:  Brandon M Shaw; Warren L Simmons; Kevin Dybvig
Journal:  Infect Immun       Date:  2011-11-14       Impact factor: 3.441

4.  Avoidance of the host immune system through phase variation in Mycoplasma pulmonis.

Authors:  Amy M Denison; Brenda Clapper; Kevin Dybvig
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

5.  Striking diversity of vmp1, a variable gene encoding a putative membrane protein of the stolbur phytoplasma.

Authors:  Agnès Cimerman; Davide Pacifico; Pascal Salar; Cristina Marzachì; Xavier Foissac
Journal:  Appl Environ Microbiol       Date:  2009-03-06       Impact factor: 4.792

Review 6.  Common strategies for antigenic variation by bacterial, fungal and protozoan pathogens.

Authors:  Kirk W Deitsch; Sheila A Lukehart; James R Stringer
Journal:  Nat Rev Microbiol       Date:  2009-06-08       Impact factor: 60.633

7.  Role of Vpma phase variation in Mycoplasma agalactiae pathogenesis.

Authors:  Rohini Chopra-Dewasthaly; Martina Baumgartner; Erika Gamper; Carmen Innerebner; Martina Zimmermann; Franz Schilcher; Alexander Tichy; Petra Winter; Wolfgang Jechlinger; Renate Rosengarten; Joachim Spergser
Journal:  FEMS Immunol Med Microbiol       Date:  2012-08-21

8.  Ureaplasma antigenic variation beyond MBA phase variation: DNA inversions generating chimeric structures and switching in expression of the MBA N-terminal paralogue UU172.

Authors:  Carl-Ulrich R Zimmerman; Renate Rosengarten; Joachim Spergser
Journal:  Mol Microbiol       Date:  2010-12-08       Impact factor: 3.501

9.  Phase-locked mutants of Mycoplasma agalactiae: defining the molecular switch of high-frequency Vpma antigenic variation.

Authors:  Rohini Chopra-Dewasthaly; Christine Citti; Michelle D Glew; Martina Zimmermann; Renate Rosengarten; Wolfgang Jechlinger
Journal:  Mol Microbiol       Date:  2008-01-30       Impact factor: 3.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.